Megmeet said on the interactive platform that the company's product types are diverse, and downstream demand is widely distributed in regions and industries. As of June 30, 2024, the company's direct export sales accounted for 34.75%, with the vast majority supplying demand from non-US regions such as India, Japan, South Korea, Southeast Asia, and Europe. Currently, the company's direct export sales business to the US accounts for less than 3% of the company's total revenue, and most of them are medical power products exempt from tariffs, and the direct impact of tariffs is limited.

Megmeet said on the interactive platform that the company's product types are diverse, and downstream demand is widely distributed in regions and industries. As of June 30, 2024, the company's direct export sales accounted for 34.75%, with the vast majority supplying demand from non-US regions such as India, Japan, South Korea, Southeast Asia, and Europe. Currently, the company's direct export sales business to the US accounts for less than 3% of the company's total revenue, and most of them are medical power products exempt from tariffs, and the direct impact of tariffs is limited.